These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24076164)

  • 21. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment.
    Fox KA; Piccini JP; Wojdyla D; Becker RC; Halperin JL; Nessel CC; Paolini JF; Hankey GJ; Mahaffey KW; Patel MR; Singer DE; Califf RM
    Eur Heart J; 2011 Oct; 32(19):2387-94. PubMed ID: 21873708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges.
    Syed TM; Halperin JL
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):428-35. PubMed ID: 17653115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience.
    Faustino A; Paiva L; Providência R; Trigo J; Botelho A; Costa M; Leitão-Marques A
    Rev Port Cardiol; 2013 Jun; 32(6):461-71. PubMed ID: 23639325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rivaroxaban for stroke prevention in atrial fibrillation and secondary prevention in patients with a recent acute coronary syndrome.
    Ahrens I; Bode C
    Future Cardiol; 2012 Jul; 8(4):533-41. PubMed ID: 22871192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation.
    Chiam PT; Ruiz CE
    J Invasive Cardiol; 2008 Apr; 20(4):E109-13. PubMed ID: 18398240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternatives to chronic warfarin therapy for the prevention of stroke in patients with atrial fibrillation.
    Lam YY; Ma TK; Yan BP
    Int J Cardiol; 2011 Jul; 150(1):4-11. PubMed ID: 21112648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left atrial appendage closure is preferred to chronic warfarin therapy: the pro perspective.
    Atoui M; Gunda S; Lakkireddy D
    Card Electrophysiol Clin; 2015 Sep; 7(3):403-13. PubMed ID: 26304519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rivaroxaban in prevention of stroke in patients with atrial fibrillation].
    Simonyi G; Medvegy M
    Ideggyogy Sz; 2012 Nov; 65(11-12):365-8. PubMed ID: 23289170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is it safe to stop anticoagulants after successful surgery for atrial fibrillation?
    Michael Gray R; Nagendran M; Maruthappu M
    Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):642-8. PubMed ID: 21885540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D; Reddy YM; Di Biase L; Vallakati A; Mansour MC; Santangeli P; Gangireddy S; Swarup V; Chalhoub F; Atkins D; Bommana S; Verma A; Sanchez JE; Burkhardt JD; Barrett CD; Baheiry S; Ruskin J; Reddy V; Natale A
    J Am Coll Cardiol; 2014 Mar; 63(10):982-8. PubMed ID: 24412445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel oral anticoagulants in secondary prevention of stroke.
    Diener HC; Easton JD; Hankey GJ; Hart RG
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interventional prevention of ischemic stroke].
    Kamtchueng P; Teiger E
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):411-8. PubMed ID: 24200350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.
    ROCKET AF Study Investigators
    Am Heart J; 2010 Mar; 159(3):340-347.e1. PubMed ID: 20211293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update and current expert opinions on percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation.
    Lewalter T; Ibrahim R; Albers B; Camm AJ
    Europace; 2013 May; 15(5):652-6. PubMed ID: 23625943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion.
    Lewalter T; Kanagaratnam P; Schmidt B; Rosenqvist M; Nielsen-Kudsk JE; Ibrahim R; Albers BA; Camm AJ
    Europace; 2014 May; 16(5):626-30. PubMed ID: 24798956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel approach to left atrial appendage exclusion: the WATCHMAN device.
    Gorodnitskiy A; Lucariello RJ; Aizer A; Coppola JT
    Cardiol Rev; 2010; 18(5):230-3. PubMed ID: 20699670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Percutaneous closure of the left atrial appendage: a new option for the prevention of thromboembolic stroke].
    Oto A; Aytemir K; Okutucu S; Kaya EB; Sahiner L; Sabanov C; Evranos B
    Turk Kardiyol Dern Ars; 2011 Dec; 39(8):668-74. PubMed ID: 22257805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Residual leaks following percutaneous left atrial appendage occlusion: assessment and management implications.
    Raphael CE; Friedman PA; Saw J; Pislaru SV; Munger TM; Holmes DR
    EuroIntervention; 2017 Nov; 13(10):1218-1225. PubMed ID: 28691914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.
    Aguilar MI; Kuo RS; Freeman WD
    Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimally invasive surgical implantation of the percutaneous left atrial appendage transcatheter occlusion device: initial experience in a canine model.
    Hill AC; Guy TS
    Innovations (Phila); 2012; 7(1):52-8. PubMed ID: 22576036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.